Activity-Based Detection of Cannabinoids in Serum and Plasma Samples
- 1 June 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 64 (6) , 918-926
Abstract
Background: Synthetic cannabinoids are the largest group of new psychoactive substances monitored by the European Monitoring Center of Drugs and Drug Addiction. The rapid proliferation of novel analogs makes the detection of these new derivatives challenging and has initiated considerable interest in the development of so-called “untargeted” screening strategies to detect these compounds. Methods: We developed new, stable bioassays in which cannabinoid receptor activation by cannabinoids led to recruitment of truncated β-arrestin 2 (βarr2) to the cannabinoid receptors, resulting in functional complementation of a split luciferase, allowing readout via bioluminescence. Aliquots (500 μ L) of authentic serum (n = 45) and plasma (n = 73) samples were used for simple liquid–liquid extraction with hexane:ethyl acetate (99:1 v/v). Following evaporation and reconstitution in 100 μ L of Opti-MEM® I/methanol (50/50 v/v), 10 μ L of these extracts was analyzed in the bioassays. Results: Truncation of βarr2 significantly (for both cannabinoid receptors; P = 0.0034 and 0.0427) improved the analytical sensitivity over the previously published bioassays applied on urine samples. The new bioassays detected cannabinoid receptor activation by authentic serum or plasma extracts, in which synthetic cannabinoids were present at low- or sub-nanogram per milliliter concentration or in which Δ9-tetrahydrocannabinol was present at concentrations >12 ng/mL. For synthetic cannabinoid detection, analytical sensitivity was 82%, with an analytical specificity of 100%. Conclusions: The bioassays have the potential to serve as a first-line screening tool for (synthetic) cannabinoid activity in serum or plasma and may complement conventional analytical assays and/or precede analytical (mass spectrometry based) confirmation.Keywords
This publication has 20 references indexed in Scilit:
- Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter SystemAnalytical Chemistry, 2017
- Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs populationDrug Testing and Analysis, 2017
- Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical reviewAnalytical and Bioanalytical Chemistry, 2017
- Mass spectrometric identification and structural analysis of the third-generation synthetic cannabinoids on the UK market since the 2013 legislative banForensic Toxicology, 2017
- Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed BioassayAnalytical Chemistry, 2016
- Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography‐tandem mass spectrometry and retrospective application to real forensic samplesDrug Testing and Analysis, 2016
- Emerging drugs of abuse: current perspectives on synthetic cannabinoidsSubstance Abuse and Rehabilitation, 2015
- Quantitative Analysis of 26 Opioids, Cocaine, and Their Metabolites in Human Blood by Ultra Performance Liquid Chromatography–Tandem Mass SpectrometryTherapeutic Drug Monitoring, 2013
- Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Analysis of Amphetamines in PlasmaJournal of Analytical Toxicology, 2011
- Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2008